S. Shelke

发表

Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial

R. Pandey, R. Guleria, S. Bhatnagar, 2021, Journal of Infection and Chemotherapy.

Ivermectin in mild and moderate COVID-19 (RIVET-COV): a randomized, placebo-controlled trial

R. Guleria, R. Pandey, S. Bhatnagar, 2021 .